Analyst Insights

Covid-19: Could Bellerphon Therapeutics’ INOpulse Help Address Hospital Ventilator Shortage?

Last year, according to the World Economic Forum, 77,000 new ventilators were enough to meet the market demand worldwide. For context, this month …

From Cancer to COVID-19, Aim ImmunoTech’s Ampligen Shows Promise

Little known biotech Aim ImmunoTech (AIM) has soared by a massive 382% year-to-date. Yet, Maxim’s analyst Jason McCarthy argues the $75 million market …

3 High-Powered Dividends Stocks With Over 7% Dividend Yield

After weeks of historic uncertainty, global stock markets are quickly settling down from now what is now nearly a month of record share …

Sorrento Provides Manufacturing Support for COVID-19 Treatment; What’s Next?

The battle against COVID-19 is well underway, and now’s the time to send in the big guns. Sorrento Therapeutics (SRNE) is on it, …

Inovio Advances COVID-19 Vaccine to Phase 1 Testing; Analyst Reiterates ‘Buy’

Amid the ongoing public health crisis, Wall Street is eagerly awaiting any piece of good news. Inovio Pharmaceuticals (INO) just came through.

Pluristem Changes the Game with Strong Preliminary COVID-19 Results; Analyst Says ‘Buy’

With the war against COVID-19 waging on, Wall Street focus has locked in on the names at the frontline. Battling a formidable opponent …

3 “Strong Buy” Precious Metal Stocks to Mine For

In times of high volatility, precious metals would see increased purchases as investors seek a safe haven. Gold, the original hard cash, is …

Morgan Stanley: 2 Stocks to Consider Buying (And 1 to Forget)

We’ve had more good news in the stock markets this week, lending credence to the view that recent gains are more than just …

Is Apple Stock a Buy Right Now? This Is What You Need to Know

Is now the right time to unleash a new product? Whether it is or not, according to one analyst, Apple (AAPL) is readying …

Put Amazon (AMZN) Stock on Your Grocery List, Says Top Analyst

Is anything going to stop Amazon’s (AMZN) march towards world domination? It certainly won’t be COVID-19.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts